Literature DB >> 34254992

Medicare and the Shocking US Food and Drug Administration Approval of Aducanumab: Crisis or Opportunity?

Francis J Crosson1, Kenneth Covinsky2,3, Rita F Redberg2,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34254992     DOI： 10.1001/jamainternmed.2021.4610

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  8 in total

1.  Instead of wasting money on aducanumab, pay for programs proven to help people living with dementia.

Authors:  Lauren J Hunt; Krista L Harrison; Kenneth E Covinsky
Journal:  J Am Geriatr Soc       Date:  2021-09-16       Impact factor: 5.562

2.  Expedited regulatory product approval in the time of COVID-19.

Authors:  Gary D Novack
Journal:  Ocul Surf       Date:  2022-05-28       Impact factor: 6.268

3.  Cost-effectiveness of Aducanumab and Donanemab for Early Alzheimer Disease in the US.

Authors:  Eric L Ross; Marc S Weinberg; Steven E Arnold
Journal:  JAMA Neurol       Date:  2022-05-01       Impact factor: 29.907

4.  Caring Together: Trajectories of Paid and Family Caregiving Support to Those Living in the Community With Dementia.

Authors:  Jennifer M Reckrey; Lihua Li; Serena Zhan; Jennifer Wolff; Cynthia Yee; Katherine A Ornstein
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2022-05-20       Impact factor: 4.942

Review 5.  The value of anticancer drugs - a regulatory view.

Authors:  Francesco Pignatti; Ulla Wilking; Douwe Postmus; Nils Wilking; Julio Delgado; Jonas Bergh
Journal:  Nat Rev Clin Oncol       Date:  2021-12-06       Impact factor: 66.675

6.  Knowledge and Attitudes Concerning Aducanumab Among Older Americans After FDA Approval for Treatment of Alzheimer Disease.

Authors:  Julie Zissimopoulos; Mireille Jacobson; Yi Chen; Soo Borson
Journal:  JAMA Netw Open       Date:  2022-02-01

Review 7.  The Emerging Role of Metabolism in Brain-Heart Axis: New Challenge for the Therapy and Prevention of Alzheimer Disease. May Thioredoxin Interacting Protein (TXNIP) Play a Role?

Authors:  Lorena Perrone; Mariarosaria Valente
Journal:  Biomolecules       Date:  2021-11-08

8.  Availability of New Medicines in the US and Germany From 2004 to 2018.

Authors:  Katharina Blankart; Huseyin Naci; Amitabh Chandra
Journal:  JAMA Netw Open       Date:  2022-08-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.